oral SERD competition FDA approval standard ESR1 mutation

Special Reports

FDA approved imlunestrant plus Verzenio for ESR1-mutated ER+ HER2- advanced breast cancer. Backed by EMBER-3, the decision reignites oral SERD standards debate and signals a...

Hots Insight Sep 27, 2026 3 0

Tag: oral SERD competition FDA approval standard ESR1 mutation

FDA Approval Inluriyo Verzenio Eli Lilly Triggers Oral SERD Race and FDA Standard Loosening

FDA Approval Inluriyo Verzenio Eli Lilly Triggers Oral SERD Race and FDA Standard Loosening

Log In / Sign Up